Effects of sydnocarb and D-amphetamine on the extracellular levels of amino acids in the rat caudate-putamen

European Journal of Pharmacology

Volumn 428, Issue 1, 2001, Pages 87-95

  Anderzhanova, Elmira ^a   Rayevsky, Kirill S ^b   Saransaari, Pirjo ^a   Riitamaa, Esa ^a   Oja, Simo S ^a,c  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b INSTITUTE OF PHARMACOLOGY   (Russian Federation)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Caudate putamen; D amphetamine; Microdialysis; Neuroactive amino acid; Neurotoxicity; Sydnocarb

Indexed keywords

ALANINE; AMINO ACID DERIVATIVE; ASPARTIC ACID; DEXAMPHETAMINE; GLUTAMIC ACID; HALOTHANE; PSYCHOSTIMULANT AGENT; SYDNOCARB; TAURINE;

AMINO ACID BRAIN LEVEL; ANIMAL EXPERIMENT; ARTICLE; CAUDATE NUCLEUS; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG STRUCTURE; INJECTION; MALE; MICRODIALYSIS; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PUTAMEN; RAT;

AMINO ACIDS; ANIMALS; CAUDATE NUCLEUS; CENTRAL NERVOUS SYSTEM STIMULANTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DEXTROAMPHETAMINE; EXTRACELLULAR SPACE; GLUTAMIC ACID; MALE; MICRODIALYSIS; PUTAMEN; RATS; RATS, SPRAGUE-DAWLEY; SYDNONES;

EID: 0035964668     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(01)01285-7     Document Type: Article

References (70)

1. Differential regulation of glutamate, aspartate and γ-amino-butyrate release by N-methyl-D-aspartate receptors in rat striatum after partial and extensive lesions to the nigro-striatal dopamine pathway
2. Effects of repeated administration of a high dose of methamphetamine on dopamine and glutamate release in rat striatum and nucleus accumbens
3. Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: Pharmacological profile of protective and non-protective agents
4. Low environmental temperatures or pharmacologic agents that produce hypothermia decrease methamphetamine neurotoxicity in mice
5. Effect of D-amphetamine and sydnocarb on the extracellular level of dopamine, 3,4-dihydroxyphenylacetic acid and hydroxyl radicals generation in rat striatum
6. Hyperpyrexia as a contributing factor in the toxicity of amphetamine in aggregated mice
7. Striatal dopamine release in vivo following neurotoxic doses of methamphetamine and effect of the neuroprotective drugs, chlormethiazole and dizocilpine
8. Enhanced acetylcholine release in striatum after chronic amphetamine is NMDA-dependent
9. The influence of environmental temperature on the transient effects of methamphetamine on dopamine levels and dopamine release in rat striatum
10. Effects of the cool environment or age on methamphetamine-induced dopamine release in the caudate-putamen of female rats
11. Futher studies of the role of hyperthermia in methamphetamine neurotoxicity
12. Neuroprotective effect of hypothermia in cortical cultures exposed to oxygen-glucose deprivation or excitatory amino acids
13. Central administration of methamphetamine synergizes with metabolic inhibition to deplete striatal monoamines
14. Free radicals and the pathology of the brain dopamine systems
15. Dopamine and N-methyl-D-aspartate receptor interaction in the neostriatum
16. Rapid ATP loss caused by methamphetamine in the mouse striatum: Relationship between energy impairment and dopaminergic neurotoxicity
17. Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implication for neurodegenerative disorders
18. Role of hyperthermia in the protective action of clomethiazole against MDMA ('ecstasy')-induced neurodegeneration, comparison with the novel NMDA channel blocker AR-R15896AR
19. Amphetamine increases the extracellular concentration of glutamate in striatum of the awake rat: Involvement of high affinity transporter mechanisms
20. Endogenous dopamine increases extracellular concentrations of glutamate and GABA in striatum of the freely moving rat: Involvement of D1 and D2 dopamine receptors
21. Role of hypothermia in the mechanism of protection against serotonergic toxicity: II. Experiments with methamphetamine, p-chloroamphetamine, fenfluramine, dizocilpine and dextromethorphan
22. Effect of acute and chronic methamphetamine treatment on tyrosine hydroxylase activity in brain and adrenal medulla
23. Pre- and postsynaptic neurotoxic effects of dopamine demonstrated by intrastriatal injections
24. Effects of a psychostimulant drug sydnocarb on rat brain dopaminergic transmission in vivo
25. Role of oxidation in the neurotoxic effect of the intrastriatal dopamine injection
26. Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity in rat brain
27. NMDA and kainate-evoked release of nitric oxide and classical transmitters in the rat striatum: In vivo evidence that nitric oxide may play a neuroprotective role
28. Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: Evidence against a role for extracellular dopamine
29. Nitric oxide and peroxynitrite exert distinct effect on the mitochondrial respiration which are differentially blocked by glutathione or glucose
30. Experimental and clinical study on new psychostimulator sydnocarb
31. Effects of MK-801 on spontaneous and amphetamine-stimulated dopamine release in striatum measured with in vivo microdialysis in awake rats
32. Environment-, drug- and stress-induced alterations in body temperature affect the neurotoxicity of substituted amphetamines in the C57BL/6J mouse
33. Methamphetamine neurotoxicity and striatal glutamate release: Comparison to 3,4-methylenedioxy-methamphetamine
34. 2 antagonists
35. Excitotoxic striatal lesions protect against subsequent methamphetamine-induced dopamine depletions
36. The role of glutamate in behavioral and neurotoxic effects of methamphetamine
37. Taurine as osmoregulator and neuromodulator in the brain
38. Modulation of taurine release by glutamate receptors and nitric oxide
39. Delta opioid receptors regulate calcium-dependent, amphetamine-evoked glutamate levels in the rat striatum: An in vivo microdialysis study
40. Cocaine and amphetamine preferentially stimulate glutamate release in the limbic system: Studies on the involvement of dopamine
41. Long term effects of repeated methylamphetamine administration on dopamine and serotonin neurons in rat brains: A regional study
42. Dopamine nerve terminals degeneration produced by high doses of methylamphetamine in the rat brain
43. Glutamatergic involvement in psychomotor stimulant action
44. Experimental and clinical study of sydnocarb
45. Release of GABA and taurine from brain slices
46. Enhanced taurine release in cell-damaging conditions in the developing and ageing mouse hippocampus
47. Release of endogenous glutamate, aspartate, GABA, and taurine from hippocampal slices from adult and developing mice under cell-damaging conditions
48. Taurine and neural cell damage
49. The role of N-methyl-D-aspartate receptors in dopaminergic neuropathology produced by the amphetamines
50. Competitive and non-competitive antagonists of N-methyl-D-aspartate receptors protect against methamphetamine-induced dopaminergic damage in mice
51. Methamphetamine-induced neurotoxicity: Role for glutamate and dopamine efflux
52. Substrates of energy metabolism attenuate methamphetamine-induced neurotoxicity in striatum
53. Cytotoxic and genotoxic potential of dopamine
54. Glutamate transporters are oxidant-vulnerable: A molecular link between oxidative and excitotoxic neurodegeneration
55. Role of high affinity receptors and membrane transporters in nonsynaptic communication and drug action in the central nervous system
56. Glutamate uptake is inhibited by arachidonic acid and oxygen radicals via two distinct and additive mechanisms
57. A possible role of alanine for ammonia transfer between astrocytes and glutamatergic neurons
58. Long lasting depletion of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine
59. MK-801 protection against methamphetamine-induced striatal dopamine terminal injury is associated with attenuated dopamine overflow
60. Behavioural, toxic, and neurochemical effects of sydnocarb, a novel psychomotor stimulant: Comparisons with methamphetamine
61. Repeated administration of MK-801 produces sensitization to its own locomotor stimulant effects but blocks sensitization to amphetamine
62. Amphetamine and D1 dopamine receptor agonists produce biphasic effects on glutamate efflux in rat ventral tegmentum area: Modification by repeated amphetamine administration
63. Amphetamine-induced glutamate efflux in the rat ventral tegmental area is prevented by MK-801, SCH 23390, and ibotenic acid lesion of the prefrontal cortex
64. Amphetamine increases glutamate efflux in the rat ventral tegmental area by a mechanism involving glutamate transporters and reactive oxygen species
65. Cytokine modulation of glial glutamate uptake: A possible involvement of nitric oxide
66. 2+ block at the N-methyl-D-aspartate receptors underlies receptor activation during inhibition of neuronal metabolism
67. Hypothermia, metabolic stress and NMDA-mediated excitotoxicity
68. NMDA receptor involvement in toxicity to dopamine neurons in vitro caused by the succinate dehydrogenase inhibitor 3-nitropropionic acid